Reactome | ravoxertinib [cytosol]

Schema > ChemicalDrug > Entries

candidateOf	[CandidateSet:R-ALL-9657577] single mechanism MAPK inhibitors [cytosol]
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9657521] Rothfels, Karen, 2019-08-08
crossReference	[DatabaseIdentifier:12020745] Mondo:0004992
dbId	9657520
disease	[Disease:1500689] cancer
displayName	ravoxertinib [cytosol]
inDisease	true
literatureReference	[LiteratureReference:9657288] Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
maxDepth	1
name	ravoxertinib
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:9229] ravoxertinib [Guide to Pharmacology:9229]
schemaClass	ChemicalDrug
stId	R-ALL-9657520

(hasCandidate)

Cite Us!